This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Acadia Healthcare (ACHC) Q1 Earnings Beat Estimates
by Zacks Equity Research
Acadia Healthcare (ACHC) delivered earnings and revenue surprises of 13.51% and -1.06%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Acadia Healthcare (ACHC) Q1 Earnings Expected to Decline
by Zacks Equity Research
Acadia Healthcare (ACHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MEDNAX Provides Updates Related to Coronavirus Pandemic
by Zacks Equity Research
MEDNAX (MD) takes several steps to help fight the COVID-19 pandemic.
Universal Health Plunges 31.4% YTD: Will It Bounce Back?
by Zacks Equity Research
Even though Universal Health (UHS) suffers the COVID-19 impact on global economy, it holds potential to stage a comeback by virtue of its solid fundamentals.
HCA Healthcare, Google Cloud Tie Up Amid Coronavirus Woes
by Zacks Equity Research
HCA Healthcare (HCA) partners Google Cloud and SADA for the COVID-19 National Response Portal, a platform to provide real-time COVID-19 updates.
Acadia Healthcare (ACHC) Down 42.6% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Acadia Healthcare (ACHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Acadia Healthcare Cancels U.K. Unit Sale on Coronavirus Crisis
by Zacks Equity Research
Acadia Healthcare (ACHC) dismisses plan to sell its U.K. business due to the economic uncertainty caused by coronavirus outbreak.
Acadia Healthcare Gains From UK Unit Sale, Solid US Business
by Zacks Equity Research
Acadia Healthcare (ACHC) is well poised for growth on several organic and inorganic growth efforts in U.S. business and the ongoing sale proceedings of U.K. operations.
Acadia Healthcare (ACHC) Q4 Earnings Top Mark, Improve Y/Y
by Zacks Equity Research
Acadia Healthcare's (ACHC) Q4 results reflect higher revenues, rise in patient days and lower expenses.
Acadia Healthcare (ACHC) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Acadia Healthcare (ACHC) delivered earnings and revenue surprises of 4.08% and 0.51%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Dose of Bright Near-Term Outlook From Medical-Hospital Industry
by Sapna Bagaria
Investment in technology, an aging population and continuous consolidation offers attractive growth opportunity for the industry.
Acadia Healthcare (ACHC) Up 5.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Acadia Healthcare (ACHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Acadia Healthcare (ACHC) Q3 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Acadia Healthcare (ACHC) delivered earnings and revenue surprises of -1.89% and -1.13%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
What to Expect From Tenet Healthcare's (THC) Q3 Earnings
by Zacks Equity Research
Tenet Healthcare's (THC) third-quarter results are likely to reflect weaker revenues, partially offset by higher contribution from its Conifer segment.
BorgWarner (BWA) to Post Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Decline in light-vehicle production across all major markets served is likely to have impacted BorgWarner's (BWA) top line in the third quarter.
Will Weak European Market Mar LKQ Corp's (LKQ) Q3 Earnings?
by Zacks Equity Research
With Europe being a major market for LKQ Corp (LKQ), lower vehicle sales amid weakening consumer demand and soft economic conditions are expected to have hampered the firm's top line in Q3.
Acadia Healthcare (ACHC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Acadia Healthcare (ACHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in Store for Molina Healthcare (MOH) Q3 Earnings?
by Zacks Equity Research
Molina Healthcare's (MOH) third-quarter results are likely to be affected by soft revenues, partly offset by improved marketplace business.
What to Expect for WellCare Health's (WCG) Earnings in Q3
by Zacks Equity Research
WellCare Health's (WCG) Q3 results are likely to reflect increased revenues and higher membership, partly offset by elevated expenses.
Why the Earnings Surprise Streak Could Continue for Acadia Healthcare (ACHC)
by Zacks Equity Research
Acadia Healthcare (ACHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Hospital Industry Outlook: Rising Baby Boomers to Drive Growth
by Sapna Bagaria
The Zacks Medical-Hospital industry is set to gain from demographic changes and growing consolidation amid high labor cost.
5 Factors That Make Acadia Healthcare Stock Look Unattractive
by Zacks Equity Research
Rising expenses, underperforming U.K business and low guidance are a drag on Acadia Healthcare's (ACHC) stock.
Here's Why You Should Avoid Acadia Healthcare Stock Now
by Zacks Equity Research
Lack of clarity on the sale of its underperforming U.K. business continues to hurt Acadia Healthcare (ACHC).
Why Is Acadia Healthcare (ACHC) Down 18% Since Last Earnings Report?
by Zacks Equity Research
Acadia Healthcare (ACHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Acadia Healthcare (ACHC) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
Acadia Healthcare (ACHC) delivered earnings and revenue surprises of 3.39% and -1.08%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?